Short interest for Horace Mann Educators gives investors a sense of the degree to which investors are betting on the decline of Horace Mann Educators's stock. Short interest data is updated every two weeks.

Horace Mann Educators Stock (NYSE:HMN), Short Interest Report

Horace Mann Educators

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The company uses several former teachers in its salesforce. Its segments include Property and Casualty, Supplemental & Group Benefits, Life & Retirement, and Corporate and Other.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACON

ARVL

BFRG

CDLX

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CRBP

New Oriental Education & Technology Group

EOLS

LCID

MDAI

MMAT

MNSO

NYXH

ONMD

PALI

PBLA

PRVA

REVB

RVSN

SLNA

SNCE

SOFI

SXTP

VLCN

ZAPP

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering.

Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

CLSK

COIN

LEVI

MARA

MGRC

TARS

WALD

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday.

Shares of  SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday

Earnings

Eurozone

Futures

Global

Pre-Market Outlook

BSGM

Pre-open movers

U.S. stock futures traded slightly higher in early pre-market trade ahead of all important jobs report. The Dow Jones jumped more than 100 points on Wednesday, while the S&amp;P 500 registered another record closing high in the earlier session.

A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Report

Horace Mann Educators Corporation Common Stock

Horace Mann Educators Corp

HMN Financial Inc

Heritage Mining Ltd

HMS Networks AB

HEMNET GROUP AB UNSP/ADR by HEMNET GROUP AB

Hemnet Group AB

HUMAN UNITEC INTL INC by Human Unitec International, Inc.

Human Unitec International Inc

HELIOS&MATHESON ANALYTICS by Helios and Matheson Analytics Inc.

Helios and Matheson Analytics Inc

Guidance

Horace Mann Educators Sees FY24 Core EPS $3.00-$3.30 Vs $3.20 Est.

Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.78 by 23.08 percent. This is a 160.87 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $386.000 million which missed the analyst consensus estimate of $399.167 million by 3.30 percent. This is a 9.07 percent increase over sales of $353.900 million the same period last year.

Earnings Misses

Horace Mann Educators Q1 2024 Adj EPS $0.60 Misses $0.78 Estimate, Sales $386.000M Miss $399.167M Estimate

Piper Sandler analyst John Barnidge maintains Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) with a Neutral and lowers the price target from $40 to $39.

Price Target

Analyst Ratings

Piper Sandler Maintains Neutral on Horace Mann Educators, Lowers Price Target to $39

Horace Mann Educators Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) today announced that its Board of Directors approved a 3.0% increase in the quarterly cash dividend to $0.34 per share. This represents an indicated annual dividend of $1.36 per share. The quarterly dividend is payable on March 29, 2024, to shareholders of record as of March 15, 2024.
"This is the 16th consecutive year the Board has increased the annual shareholder cash dividend, reflecting Horace Mann's commitment to long-term shareholder value creation," said Horace Mann President &amp; CEO Marita Zuraitis.
The company also noted that it continues to expect full-year 2024 earnings per share between $3.00-$3.30 with the Property &amp; Casualty segment expected to return to full-year profitability.

Dividends

Horace Mann Increases Quarterly Shareholder Dividend From $0.33 To $0.34 Per Share

Horace Mann Educators Sees FY24 EPS $3.00-$3.30

Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported its Q4 earnings results on Wednesday, February 7, 2024 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Horace Mann Educators beat estimated earnings by 27.27%, reporting an EPS of $0.84 versus an estimate of $0.66.
Revenue was up $56.10 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 3.22% increase in the share price the next day.
Here's a look at Horace Mann Educators's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.44</td>
<td>0.03</td>
<td>0.21</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.44</td>
<td>0.03</td>
<td>0.23</td>
<td>-0.11</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>384.40M</td>
<td>375.40M</td>
<td>367.43M</td>
<td>347.03M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>378.70M</td>
<td>356.40M</td>
<td>353.90M</td>
<td>346.80M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Horace Mann Educators <a href="https://www.benzinga.com/quote/HMN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Horace Mann Educators Q4 Earnings

Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.66 by 27.27 percent. The company reported quarterly sales of $402.90 million which beat the analyst consensus estimate of $393.33 million by 2.43 percent. This is a 16.31 percent increase over sales of $346.40 million the same period last year.

Earnings Beats

Horace Mann Educators Q4 2023 Adj EPS $0.84 Beats $0.66 Estimate, Sales $402.90M Beat $393.33M Estimate

ACLS

ADNT

ALCO

APPS

ARCC

ASGN

ASND

AVXL

AZTA

BABA

BARK

BERY

BLBD

CDAY

CENT

CENTA

CFLT

CMRE

COTY

CRTO

CSGS

EEFT

ENTA

EQNR

FLNC

FLNG

FORM

FOXA

GEOS

GPRE

GPRO

HAIN

INTR

MCFT

MKSI

MPWR

MSGE

MTRX

NBIX

NOTV

NTGR

NVST

NWSA

OESX

ORLY

OSCR

PAHC

Earnings Scheduled For February 7, 2024

Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-02-07. Here's what investors need to know before the announcement.
Analysts estimate that Horace Mann Educators will report an earnings per share (EPS) of $0.66. 
Horace Mann Educators bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 3.22% increase in the share price the next day.
Here's a look at Horace Mann Educators's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.44</td>
<td>0.03</td>
<td>0.21</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.44</td>
<td>0.03</td>
<td>0.23</td>
<td>-0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.22%</td>
<td>-4.14%</td>
<td>4.88%</td>
<td>-1.93%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1707242479_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Horace Mann Educators were trading at $35.4 as of February 05. Over the last 52-week period, shares are up 0.38%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/HMN/earnings">To track all earnings releases for Horace Mann Educators visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Horace Mann Educators's Earnings Outlook

Shares of Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) fell sharply during Monday&rsquo;s session after the company announced pricing of a roughly $9 million public offering.
Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Palisade Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pali#NASDAQ">PALI</a>) shares jumped 133.8% to $1.2250 after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn&#39;s &amp; Colitis Congress.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) surged 95% to $1.0401. OneMedNet announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit.</li>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares climbed 65.8% to $16.37.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) gained 60% to $15.12.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) jumped 43% to $0.2200.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) surged 35.3% to $0.7830.</li>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) surged 28% to $7.40 after the company announced it entered into a settlement agreement with SRS and updated preliminary Q4 2023 results.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) gained 23% to $3.2703.</li>
<li>Nyxoah S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nyxh#NASDAQ">NYXH</a>) rose 22.5% to $11.53.</li>
<li>Spectral AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdai#NASDAQ">MDAI</a>) climbed 20.2% to $3.2580 after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4.</li>
<li>SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) rose 20% to $9.16 after the company reported better-than-expected quarterly revenue.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) gained 20% to $0.3310.</li>
<li>Science 37 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snce#NASDAQ">SNCE</a>) jumped 16.4% to $5.68 as the company agreed to be acquired by eMed.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) rose 16% to $0.1411.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) gained 12.8% to $0.9063.</li>
<li>Evolus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eols#NASDAQ">EOLS</a>) gained 12.4% to $13.41 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $10 to $16.</li>
<li>Jianzhi Education Technology Group Company Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jz#NASDAQ">JZ</a>) gained 9.7% to $0.6818.</li>
<li>Horace Mann Educators Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmn#NYSE">HMN</a>) gained 9% to $38.13. Keefe, Bruyette &amp; Woods analyst Meyer Shields upgraded Horace Mann Educators from Market Perform to Outperform.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zapp#NASDAQ">ZAPP</a>) shares rose 7.9% to $0.2783 after dipping 12% on Friday.</li>
<li>60 Degrees Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtp#NASDAQ">SXTP</a>) surged 7.5% to $0.5378. 60 Degrees Pharmaceuticals recently announced that, following a Type C meeting held on Jan. 17, 2024, with the FDA, the company will move forward with a pivotal clinical study of tafenoquine in hospitalized babesiosis patients in the U.S.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>SMX (Security Matters) Public Limited Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smx#NYSE">SMX</a>) fell 24.2% to $0.3259 after gaining around 83% on Friday.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) shares declined 23.4% to $0.1710 after surging 17% on Friday.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) fell 22.6% to $5.44. Bullfrog AI filed shelf offering of 786,938 shares and accompanying warrants at $6.63/share and accompanying warrant.</li>
<li>Psyence Therapeutics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) declined 19.1% to $1.90.</li>
<li>Meta Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmat#NASDAQ">MMAT</a>) declined 18.4% to $4.7501.</li>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) shares fell 18.2% to $2.32 after surging 52% on Friday.</li>
<li>Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crbp#NASDAQ">CRBP</a>) fell 17.4% to $24.33. Corbus Pharmaceuticals shares jumped 249% on Friday after the company announced data from the first-in-human clinical study of CRB-701 is being presented as a poster by its development partner CSPC Pharmaceutical at ASCO GU 2024.</li>
<li>Richtech Robotics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rr#NASDAQ">RR</a>) fell 17% to $2.8813.</li>
<li>Arrival (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arvl#NASDAQ">ARVL</a>) fell 14.1% to $0.6346.</li>
<li>J-Long Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jl#NASDAQ">JL</a>) dipped 12.4% to $8.80 amid post-<a href="https://www.benzinga.com/news/ipos">IPO</a> volatility.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) fell 10.5% to $10.52. The company recently posted upbeat quarterly sales.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) shares declined 10.4% to $0.2381 after gaining around 24% on Friday.</li>
<li>MINISO Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NYSE">MNSO</a>) fell 10.3% to $17.76.</li>
<li>GigaCloud Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gct#NYSE">GCT</a>) declined 10.1% to $23.03.</li>
<li>New Oriental Education &amp; Technology Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/edu#NYSE">EDU</a>) dipped 7.7% to $73.77. New Oriental recently reported better-than-expected second-quarter sales results.</li>
<li>Privia Health Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prva#NASDAQ">PRVA</a>) fell 7.7% to $21.09.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) fell 7.5% to $11.53 after B of A Securities downgraded the stock from Neutral to Underperform.</li>
<li>Koninklijke Philips N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phg#NYSE">PHG</a>) shares dipped 6% to $21.41 after the company reported fourth-quarter results and agreed on a settlement with the FDA, primarily focusing on Philips Respironics&rsquo; business operations in the U.S.</li>
</ul>
&nbsp;
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36825211/bitcoin-ethereum-edge-lower-pyth-network-becomes-top-loser"> Bitcoin, Ethereum Edge Lower; Pyth Network Becomes Top Loser</a>

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday.
Shares of SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) rose sharply during Monday&rsquo;s session after the company reported better-than-expected fourth-quarter revenue.
Adjusted revenue increased 34% year-on-year to $594.25 million, beating the consensus of $571.70 million. The adjusted EPS of 2 cents beat the consensus of 0 cents.
SoFi Technologies shares gained 20% to $9.16 on Monday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) shares jumped 28% to $7.40 after the company announced it entered into a settlement agreement with SRS and updated preliminary fourth-quarter 2023 results.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) climbed 23% to $3.2703.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) rose 12.8% to $0.9063.</li>
<li>Evolus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eols#NASDAQ">EOLS</a>) climbed 12.4% to $13.41 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $10 to $16.</li>
<li>Tarsus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tars#NASDAQ">TARS</a>) rose 10.2% to $28.43.</li>
<li>McGrath RentCorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgrc#NASDAQ">MGRC</a>) gained 9.7% to $122.60 after WillScot Mobile Mini agreed to acquire the company for $3.8 billion.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) climbed 9.6% to $1.26. Pagaya Technologies recently said it expects preliminary 2023 network volume and adjusted EBITA to exceed the high end of its outlook ranges.</li>
<li>Horace Mann Educators Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmn#NYSE">HMN</a>) rose 9% to $38.13. Keefe, Bruyette &amp; Woods analyst Meyer Shields upgraded Horace Mann Educators from Market Perform to Outperform.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) gained 8.8% to $8.72.</li>
<li>Waldencast plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wald#NASDAQ">WALD</a>) rose 7.8% to $8.27.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) jumped 7.1% to $3.32.</li>
<li>ZoomInfo Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zi#NASDAQ">ZI</a>) gained 6.7% to $16.94 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $20 to $25.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) rose 6.2% to $132.92.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 5.5% to $18.83.</li>
<li>Rumble Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rum#NASDAQ">RUM</a>) gained 5% to $6.34.</li>
<li>Levi Strauss &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/levi#NYSE">LEVI</a>) rose 3.5% to $16.50. Levi Strauss &amp; Co reported upbeat earnings for its fourth quarter on Thursday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/01/36823065/top-3-consumer-stocks-that-may-crash-in-january"> Top 3 Consumer Stocks That May Crash In January</a>

Keefe, Bruyette &amp; Woods analyst Meyer Shields upgrades Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) from Market Perform to Outperform and announces $40 price target.

Upgrades

Keefe, Bruyette & Woods Upgrades Horace Mann Educators to Outperform, Announces $40 Price Target

By the end of today, December 18, 2023, Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>) is set to deliver a dividend payout of $0.72 per share, equating to an annualized dividend yield of 1.81%. Shareholders who owned the stock prior to the ex-dividend date on November 24, 2023 will receive this payout.
<h3>Assurant Recent Dividend Payouts</h3>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style><table>
<thead>
<tr>
<th>Ex-Date</th>
<th style="text-align: right;">Payments per year</th>
<th>Dividend</th>
<th>Yield</th>
<th>Announced</th>
<th>Record</th>
<th>Payable</th>
</tr>
</thead>
<tbody>
<tr>
<td>2023-11-24</td>
<td style="text-align: right;">4</td>
<td>$0.72</td>
<td>1.81%</td>
<td>2023-11-09</td>
<td>2023-11-27</td>
<td>2023-12-18</td>
</tr>
<tr>
<td>2023-08-25</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>1.99%</td>
<td>2023-08-10</td>
<td>2023-08-28</td>
<td>2023-09-18</td>
</tr>
<tr>
<td>2023-05-26</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.17%</td>
<td>2023-05-11</td>
<td>2023-05-30</td>
<td>2023-06-20</td>
</tr>
<tr>
<td>2023-02-24</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.2%</td>
<td>2023-01-19</td>
<td>2023-02-27</td>
<td>2023-03-20</td>
</tr>
<tr>
<td>2022-11-25</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>2.28%</td>
<td>2022-11-10</td>
<td>2022-11-28</td>
<td>2022-12-19</td>
</tr>
<tr>
<td>2022-08-26</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.77%</td>
<td>2022-08-04</td>
<td>2022-08-29</td>
<td>2022-09-19</td>
</tr>
<tr>
<td>2022-05-27</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.51%</td>
<td>2022-05-12</td>
<td>2022-05-31</td>
<td>2022-06-20</td>
</tr>
<tr>
<td>2022-02-25</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.74%</td>
<td>2022-01-11</td>
<td>2022-02-28</td>
<td>2022-03-21</td>
</tr>
<tr>
<td>2021-11-26</td>
<td style="text-align: right;">4</td>
<td>$0.68</td>
<td>1.7%</td>
<td>2021-11-10</td>
<td>2021-11-29</td>
<td>2021-12-20</td>
</tr>
<tr>
<td>2021-08-27</td>
<td style="text-align: right;">4</td>
<td>$0.66</td>
<td>1.73%</td>
<td>2021-07-23</td>
<td>2021-08-30</td>
<td>2021-09-21</td>
</tr>
<tr>
<td>2021-05-28</td>
<td style="text-align: right;">4</td>
<td>$0.66</td>
<td>1.66%</td>
<td>2021-05-19</td>
<td>2021-06-01</td>
<td>2021-06-22</td>
</tr>
<tr>
<td>2021-02-19</td>
<td style="text-align: right;">4</td>
<td>$0.66</td>
<td>1.92%</td>
<td>2021-01-12</td>
<td>2021-02-22</td>
<td>2021-03-15</td>
</tr>
</tbody>
</table>
Assurant's dividend yield falls in the middle range when compared to its industry peers, with Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) having the highest annualized dividend yield at 4.06%.
<h3>Analyzing Assurant Financial Health</h3>
Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. 
<h3>YoY Growth in Dividend Per Share</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1702911922_0.png" alt="dividend chart graph" />
During the period of 2019 to 2022, the company experienced a notable growth in its dividend per share. The dividend per share increased from $2.43 to $2.74, reflecting the company's focus on providing greater returns to its shareholders.
<h3>YoY Earnings Growth For Assurant</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1702911922_1.png" alt="earning chart graph" />
The earnings chart illustrates an increase in Assurant's earnings per share, from $7.13 in 2019 to $10.18 in 2022. This positive earnings growth provides income-seeking investors with optimism, as it suggests potential for higher cash dividend payouts in the future.
<h3>Recap</h3>
This article takes an in-depth look at Assurant's recent dividend payout and its implications for shareholders. The company is currently distributing a dividend of $0.72 per share today, translating to an annualized dividend yield of 1.81%.
Assurant's dividend yield falls in the middle range when compared to its industry peers, with Horace Mann Educators having the highest annualized dividend yield at 4.06%.
The upward trend in dividend per share and earnings per share for Assurant from 2019 to 2022 reflects a strong financial position, supporting the company's ability to consistently distribute profits to their investors.
To stay well-informed about potential changes in financials or dividend disbursements, investors should closely observe the company's performance in the upcoming quarters.
[Track real-time stock fluctuations for Assurant on Benzinga.](https://www.benzinga.com/quote/Assurant (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aiz#NYSE">AIZ</a>))
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assurant Demonstrates Strong Performance and Increased Profits, Maximizing Returns for Shareholders

Tuesday marks the last chance for investors to receive the next dividend payout from Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>). 
<h3>What's Happening</h3>
The company announced on Monday that it would pay shareholders a quarterly dividend of 33 cents per share. On Wednesday, Horace Mann Educators will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 33 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own HMN as of the end of Tuesday's session are eligible to receive the 33 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on December 29, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Horace Mann Educators's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Horace Mann Educators: Dividend Insights

Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported quarterly earnings of $0.44 per share which met the analyst consensus estimate. This is a 22.81 percent decrease over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $378.70 million which missed the analyst consensus estimate of $384.40 million by 1.48 percent. This is a 10.41 percent increase over sales of $343.00 million the same period last year.

Horace Mann Educators Q3 2023 Adj EPS $0.44, Inline, Sales $378.70M Miss $384.40M Estimate

Horace Mann Educators Prices Offering Of $300M Of 7.250% Senior Notes Due 2028

Wednesday marks the last chance for investors to receive the next dividend payout from Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>). 
<h3>What's Happening</h3>
The company announced on Tuesday that it would pay shareholders a quarterly dividend of 33 cents per share. On Thursday, Horace Mann Educators will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 33 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own HMN as of the end of Wednesday's session are eligible to receive the 33 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on September 29, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Horace Mann Educators's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. This is a 400 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $356.40 million which missed the analyst consensus estimate of $375.40 million by 5.06 percent. This is a 2.92 percent increase over sales of $346.30 million the same period last year.

Horace Mann Educators Q2 EPS $0.03, Inline, Sales $356.40M Miss $375.40M Estimate

<ul>
<li>Q2&nbsp;core EPS&#x2A; expected to be between&nbsp;$0.01&nbsp;and&nbsp;$0.03&nbsp;as the benefits of diversification offset weather impact on Property &amp; Casualty segment results</li>
<li>Longer-term&nbsp;outlook&nbsp;largely unchanged due to accelerating impact of P&amp;C rate actions and growing significance of new Worksite business</li>
</ul>
Horace Mann Educators Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) today announced it expects&nbsp;second-quarter&nbsp;2023 core EPS in the range of&nbsp;$0.01&nbsp;to&nbsp;$0.03. Continued strong performance of the company&#39;s Worksite and Life &amp; Retirement businesses offset the impact of outsized weather activity across the country, which was also a primary factor in continued elevated auto loss frequency.
Second-quarter&nbsp;catastrophe losses are now expected to be between&nbsp;$41 million&nbsp;to&nbsp;$43 million, pretax. In total, there were 19 events designated as catastrophes by Property Claims Services (PCS) in this year&#39;s&nbsp;second quarter, including multiple severe convective storms across the Midwest and Texas in June. Catastrophe losses are expected to contribute 26 to 27 points to the&nbsp;second-quarter&nbsp;combined ratio.
&quot;Across the country, weather events are increasing in frequency and size, resulting in record levels of catastrophe losses for the industry,&quot; said President &amp; CEO Marita Zuraitis. &quot;I am proud of our team members who continuously deliver on Horace Mann&#39;s promise to help affected educator customers at the &lsquo;moment of truth.&#39;
&quot;Second-quarter&nbsp;underlying Property &amp; Casualty results confirm we took appropriate reserve actions in 2022 to address the emergence of the post-pandemic inflationary loss environment,&quot; added Zuraitis. &quot;Auto rate increases since the beginning of 2022 have reached almost&nbsp;15%&nbsp;nationwide, and we expect the cumulative year-end impact to be near&nbsp;20%. Further, we expect average renewal premiums for property to increase by&nbsp;17%&nbsp;to&nbsp;20%&nbsp;in 2023 due to rate increases and other actions. We will continue to address the increased weather activity through additional filed rate, product changes and enhanced modeling.
&quot;Our expected results for the&nbsp;second quarter, as well our&nbsp;outlook, benefit from the significant revenue and earnings diversification efforts we&#39;ve undertaken in the past five years,&quot; Zuraitis continued. &quot;Strong contributions from our Worksite and Life &amp; Retirement businesses, combined with continued progress toward P&amp;C segment profitability targets, should enable us to deliver 2023 core EPS in the range of&nbsp;$1.20&nbsp;to&nbsp;$1.45. We continue to see sales momentum across our entire business and we remain confident in our long-term&nbsp;outlook.
Full-year 2023 EPS&nbsp;guidance&nbsp;now reflects an increase in the full-year catastrophe loss estimate to&nbsp;$95 million&nbsp;to&nbsp;$100 million&nbsp;to acknowledge the potential for continued outsized weather through the second half.
Second-quarter&nbsp;2023 financial results to be announced on August 1
Horace Mann plans to release its&nbsp;second-quarter&nbsp;2023 results on August 1, after the market closes. Management will host a conference call to discuss the financial results on August 2 at 12:30 p.m. Eastern Time. Investors can access the call webcast via the Events page of the company&#39;s investor site or by dialing&nbsp;844-735-3325. For the webcast, please log on to the site several minutes in advance to register and download any required audio software. On-demand replay will be available later that day.

Horace Mann Announces Q2 Catastrophe Losses Between $41M-$43M, Pre-Tax, As Weather-Driven Losses Rise Across Industry; Sees Q2 EPS $0.01-$0.03

<h1>&nbsp;</h1>
On Thursday, 64 companies achieved new lows for the year.
<h2>Key Facts About Today&#39;s 52-Week Lows:</h2>
<ul>
<li>Royalty Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) was the largest company by market cap to set a new 52-week low.</li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) was the smallest company in terms of market cap to set a new 52-week low.</li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) shares dropped the most, trading down 54.71% to reach its new 52-week low.</li>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.</li>
</ul>
The following stocks set new 52-week lows on Thursday:
<ul>
<li>Royalty Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) stock hit $31.96 on Thursday morning, setting a new 52-week low for a change of down 0.47%.</li>
<li>Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) stock hit $82.32 on Thursday morning, setting a new 52-week low for a change of down 1.71%.</li>
<li>TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) shares reached a new 52-week low of $15.09 on Thursday morning, moving up 0.69%.</li>
<li>National Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSA#NYSE">NSA</a>) stock hit a yearly low of $34.58. The stock was down 0.03% for the day.</li>
<li>Atlantica Sustainable (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AY#NASDAQ">AY</a>) shares fell to $23.60 on Thursday, setting a new 52-week low with a shift of down 0.46%.</li>
<li>John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) stock achieved a new 52-week low on Thursday morning, hitting $32.14 and moving down 9.67%.</li>
<li>Safehold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) stock achieved a new 52-week low on Thursday morning, hitting $23.12 and moving down 0.4%.</li>
<li>AdaptHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) shares made a new 52-week low of $9.85 on Thursday. The stock was down 0.45% for the day.</li>
<li>Veradigm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDRX#NASDAQ">MDRX</a>) stock broke to a new 52-week low of $11.43 on Thursday. Shares of the company traded down 0.35%.</li>
<li>Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) stock achieved a new 52-week low on Thursday morning, hitting $29.37 and moving down 1.27%.</li>
<li>Chijet Motor Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJET#NASDAQ">CJET</a>) shares set a new yearly low of $3.23 this morning. The stock was down 10.25% on the session.</li>
<li>Sohu.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHU#NASDAQ">SOHU</a>) shares moved down 1.79% on Thursday to hit a new 52-week low of $11.11, drifting down 1.79%.</li>
<li>Canopy Gwth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) stock set a new 52-week low of $0.64 on Thursday, moving down 2.76%.</li>
<li>PetMed Express (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) stock dropped to a yearly low on Thursday of $13.37. Shares traded down 3.11%.</li>
<li>Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) stock drifted down 0.51% on Thursday morning to hit a new 52-week low of $0.40.</li>
<li>SoundThinking (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSTI#NASDAQ">SSTI</a>) shares were down 0.85% for the day, having made a 52-week low of $21.10.</li>
<li>Karyopharm Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) shares moved down 1.91% on Thursday to hit a new 52-week low of $2.00, drifting down 1.91%.</li>
<li>Douglas Elliman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOUG#NYSE">DOUG</a>) shares reached a new 52-week low of $2.42 on Thursday morning, moving down 6.82%.</li>
<li>Tredegar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TG#NYSE">TG</a>) stock broke to a new 52-week low of $6.07 on Thursday. Shares of the company traded down 5.15%.</li>
<li>Adicet Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACET#NASDAQ">ACET</a>) stock hit a new 52-week low of $4.40. The stock was down 1.1% on the session.</li>
<li>Star Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STHO#NASDAQ">STHO</a>) shares reached a new 52-week low of $13.83 on Thursday morning, moving down 1.51%.</li>
<li>PolyMet Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLM#AMEX">PLM</a>) shares set a new yearly low of $0.80 this morning. The stock was down 0.48% on the session.</li>
<li>Edgio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGIO#NASDAQ">EGIO</a>) stock dropped to a yearly low on Thursday of $0.45. Shares traded up 2.08%.</li>
<li>ViewRay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAY#NASDAQ">VRAY</a>) shares moved down 1.69% on Thursday to hit a new 52-week low of $0.47, drifting down 1.69%.</li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock hit a yearly low of $0.20. The stock was up 18.18% for the day.</li>
<li>Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) shares fell to $0.91 on Thursday, setting a new 52-week low with a shift of up 0.05%.</li>
<li>JOANN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOAN#NASDAQ">JOAN</a>) stock hit $0.95 on Thursday morning, setting a new 52-week low for a change of down 1.2%.</li>
<li>Eledon Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) shares moved up 1.17% on Thursday to hit a new 52-week low of $1.60, drifting up 1.17%.</li>
<li>HEXO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEXO#NASDAQ">HEXO</a>) stock drifted down 4.77% on Thursday morning to hit a new 52-week low of $0.73.</li>
<li>Trio Petroleum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TPET#AMEX">TPET</a>) stock broke to a new 52-week low of $1.25 on Thursday. Shares of the company traded down 2.95%.</li>
<li>Akumin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKU#NASDAQ">AKU</a>) stock hit a new 52-week low of $0.30. The stock was up 1.8% on the session.</li>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) stock hit a new 52-week low of $0.55. The stock was 0.0% (flat) on the session.</li>
<li>AERWINS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) stock hit $0.44 on Thursday morning, setting a new 52-week low for a change of down 2.44%.</li>
<li>Stronghold Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDIG#NASDAQ">SDIG</a>) shares set a new yearly low of $3.84 this morning. The stock was down 2.69% on the session.</li>
<li>Brera Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BREA#NASDAQ">BREA</a>) stock set a new 52-week low of $1.70 on Thursday, moving up 4.55%.</li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares set a new 52-week low of $0.55. The stock traded down 2.92%.</li>
<li>VistaGen Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTGN#NASDAQ">VTGN</a>) shares fell to $2.03 on Thursday, setting a new 52-week low with a shift of up 1.19%.</li>
<li>Hempacco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPCO#NASDAQ">HPCO</a>) shares set a new yearly low of $0.45 this morning. The stock was down 0.38% on the session.</li>
<li>China Jo-Jo Drugstores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJJD#NASDAQ">CJJD</a>) shares reached a new 52-week low of $0.52 on Thursday morning, moving down 25.88%.</li>
<li>Bit Brother (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTB#NASDAQ">BTB</a>) shares were down 1.74% for the day, having made a 52-week low of $0.73.</li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) stock hit $0.28 on Thursday morning, setting a new 52-week low for a change of down 16.16%.</li>
<li>EBET (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBET#NASDAQ">EBET</a>) stock drifted down 1.65% on Thursday morning to hit a new 52-week low of $0.19.</li>
<li>Senmiao Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIHS#NASDAQ">AIHS</a>) stock drifted down 14.46% on Thursday morning to hit a new 52-week low of $0.65.</li>
<li>Smart for Life (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) stock drifted down 10.0% on Thursday morning to hit a new 52-week low of $1.07.</li>
<li>Edible Garden AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>) stock dropped to a yearly low on Thursday of $1.45. Shares traded down 2.17%.</li>
<li>Agile Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRX#NASDAQ">AGRX</a>) stock dropped to a yearly low on Thursday of $3.08. Shares traded down 9.77%.</li>
<li>Staffing 360 Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) stock set a new 52-week low of $0.65 on Thursday, moving up 13.09%.</li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares made a new 52-week low of $1.87 on Thursday. The stock was down 7.17% for the day.</li>
<li>OncoSec Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCS#NASDAQ">ONCS</a>) shares set a new 52-week low of $0.18. The stock traded down 48.03%.</li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) shares set a new 52-week low of $1.78. The stock traded down 54.71%.</li>
</ul>
Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Learn more here</a>.

Options

ACET

AGRX

AHCO

AIHS

AWIN

BBLG

BREA

CJET

CJJD

CNXC

DOUG

EBET

EDBL

EGIO

ELDN

HEXO

HPCO

JOAN

KPTI

MBRX

MDRX

MULN

NUTX

ONCS

PASG

PETS

RPRX

SAFE

SDIG

SMFL

SOHU

SSTI

STAF

STHO

TIXT

TPET

VRAY

VTGN

ZVSA

Stocks That Hit 52-Week Lows On Thursday

KBW analyst Meyer Shields maintained a Buy rating on Horace Mann Educators (HMN – Research Report) on March 22 and set a price target of $42.00. Th...

Horace Mann Educators (HMN) Gets a Buy from KBW

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Check out the guide to the best <a href="https://investorplace.com/stock-types/dividend-stocks/">dividend stocks</a> that can help you achieve financial freedom. The first star in this investing galaxy, with a 5% dividend yield, is glowing brightly. The firm is not just a passive investment; it is a dynamic force positioned for exponential expansion, with a strategic focus on growing market share and strengthening its branch network.



Examining the dividend universe in more detail, the second one has a respectable 2.4% prospective dividend yield. Supported by its strong capitalization and unwavering position in the Mexican market, the firm presents itself as a solid financial stability pillar, offering steady returns to astute investors pursuing long-term success.



However, the adventure is far from over. The third one is a promising investment due to its alluring 3.8% dividend yield. With record-breaking premium growth, the firm is headed for unheard-of financial success, which is symptomatic of skyrocketing demand for its insurance products. Read more to learn the fundamentals of financial freedom through these dividend raptors.



<h2>Northrim BanCorp (NRIM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-moneybag-300x169.jpg" alt="image of hands holding small money bag symbolizing dividend stocks"><div>Source: Shutterstock</div></div>The dividend yield (forward) that Northrim BanCorp (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrim-stock-quote/">NRIM</a>) provides<a href="https://seekingalpha.com/symbol/NRIM/dividends/scorecard" target="_blank">&nbsp;is 5%</a>. The average interest-bearing deposit for Q4 2023<a href="https://www.globenewswire.com/news-release/2024/01/25/2817403/8875/en/Northrim-BanCorp-Earns-6-6-million-or-1-19-Per-Diluted-Share-in-Fourth-Quarter-2023-and-25-4-Million-or-4-49-Per-Diluted-Share-for-the-Year-Ended-December-31-2023.html" target="_blank">&nbsp;increased by 6%</a>&nbsp;from Q3 and 9% from Q4 2022. Northrim BanCorp&rsquo;s development trajectory is primarily attributed to its persistent attempts to increase its branch network and market share. The rise in average interest-bearing deposits demonstrates the efficacy of the business&rsquo;s tactics in luring and keeping consumer deposits.



Moreover, Northrim&rsquo;s emphasis on liquidity management guarantees its stability in the face of economic fluctuations. This, in turn, promotes depositor trust and opens up new avenues for growth. Furthermore, as of 2023, the total loans in the portfolio were&nbsp;<a href="https://www.globenewswire.com/news-release/2024/01/25/2817403/8875/en/Northrim-BanCorp-Earns-6-6-million-or-1-19-Per-Diluted-Share-in-Fourth-Quarter-2023-and-25-4-Million-or-4-49-Per-Diluted-Share-for-the-Year-Ended-December-31-2023.html" target="_blank">$1.79 billion</a>, up 4% from the previous quarter and 19% from 2022. 



Additionally, Northrim BanCorp&rsquo;s community banking business has demonstrated substantial success. This can be seen in the consistent expansion of portfolio loans and total deposits. Hence, the main drivers of this expansion are the development of a new clientele, the increase in market share, and the retention of mortgages.&nbsp;



Finally, the firm is strengthening its income base. Thus, as long as it keeps attracting deposits and making loans, it creates a solid basis for future growth.



<h2>International Bancshares (IBOC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/dividends_1600_chart-300x169.png" alt='A photo of a paper with a chart and the word "Dividends" written on it, with a pen and calculator resting on top of it.'><div>Source: jittawit21/Shutterstock.com</div></div>The dividend yield for International Bancshares (NASDAQ:<a href="https://investorplace.com/stock-quotes/iboc-stock-quote/">IBOC</a>) is&nbsp;<a href="https://seekingalpha.com/symbol/IBOC/dividends/scorecard" target="_blank">2.4% going forward</a>. The total amount of money that International Bancshares reported being available to pay dividends from its subsidiary banks in 2023 was almost&nbsp;<a href="https://www.ibc.com/resourcefiles/sec-filings-by-ibc/december-2023-10k-with-exhibits.pdf?version=3152024142431" target="_blank">$1.3 billion.</a>&nbsp;This is an important measure of the holding company&rsquo;s ability to obtain dividend payments from its bank subsidiaries.



Moreover, International Bancshares may use all $1.3 billion and remain &ldquo;well capitalized&rdquo; under the capital regulations in effect on December 31, 2023. This shows that International Bancshares&rsquo;s regulatory capital needs and dividend payment potential are in line. International Bancshares exhibits a solid financial position that supports stability and expansion, as evidenced by its capacity to pay dividends and surpass regulatory minimums.



International Bancshares is well-established and stable in the Mexican market, especially in the northern region. The deposits made by clients and entities in Mexico mark a considerable fraction of the deposit base held by its subsidiary banks. Hence, these deposits held around&nbsp;<a href="https://www.ibc.com/resourcefiles/sec-filings-by-ibc/december-2023-10k-with-exhibits.pdf?version=3152024142431" target="_blank">29%, 28%, and 25%</a>&nbsp;of the total deposits held by the subsidiary banks for 2023, 2022, and 2021.



<h2>Horace Mann (HMN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/11/dividends-1600-300x169.jpg" alt='stock market ticker screen with the word "dividends" appearing in large text. Must-Have Dividend Stocks. Dividend kings to own'><div>Source: iQoncept/shutterstock.com</div></div>A core performance indicator for insurance companies such as Horace Mann (NYSE:<a href="https://investorplace.com/stock-quotes/hmn-stock-quote/">HMN</a>) is premium growth, which indicates their products&rsquo; popularity. The company offers a&nbsp;<a href="https://seekingalpha.com/symbol/HMN/dividends/scorecard" target="_blank">3.8% forward dividend yield</a>. In 2023, Horace Mann recorded record net premiums written and&nbsp;<a href="https://s25.q4cdn.com/396928235/files/doc_financials/2023/q4/horace-mann-educators-corporation_earnings-call_2024-02-08.pdf" target="_blank">$1.5 billion in contract deposits</a>, demonstrating the high demand for the insurance products the business offers. The considerable rise in deposits and premiums indicates the business&rsquo;s capacity to attract clients in a highly competitive market.



Furthermore, the Property &amp; Casualty category had an increase in premiums. This is an&nbsp;<a href="https://s25.q4cdn.com/396928235/files/doc_financials/2023/q4/horace-mann-educators-corporation_earnings-call_2024-02-08.pdf" target="_blank">11% increase in 2023</a>&nbsp;over the previous year. This expansion demonstrates how well the business has driven premium growth in a challenging market environment through its underwriting initiatives and pricing methods.



Finally, the efficacy of the company&rsquo;s underwriting efforts and price changes was demonstrated by the notable increase in vehicle premiums caused by the cumulative impact of rate actions. Therefore, the rise in vehicle insurance rates highlights Horace Mann&rsquo;s aptitude for risk management and competitive insurance pricing.



<h2>Trinity (TRN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-letters-300x169.jpg" alt="dividend stocks"><div>Source: Shutterstock</div></div>Trinity (NYSE:<a href="https://investorplace.com/stock-quotes/trn-stock-quote/">TRN</a>) produces a forward dividend yield of&nbsp;<a href="https://seekingalpha.com/symbol/TRN/dividends/scorecard" target="_blank">more than 4%</a>. The company shows good railcar delivery performance and has a healthy backlog. This suggests that there is a constant need for its products. In 2023, the firm recorded deliveries of&nbsp;<a href="https://s25.q4cdn.com/774532758/files/doc_earnings/2023/q4/earnings-result/Exh-99-1-Press-Release-02-22-2024.pdf" target="_blank">17,355 railcars</a>, of which 4,000 were made in Q4 alone. Despite obstacles like border closures that hinder shipping, Trinity showed tenacity in satisfying client needs and completing orders.



With a sizable backlog of&nbsp;<a href="https://s25.q4cdn.com/774532758/files/doc_earnings/2023/q4/earnings-result/Exh-99-1-Press-Release-02-22-2024.pdf" target="_blank">$3.2 billion</a>&nbsp;at year&rsquo;s end, Trinity can plan operations efficiently and pursue new business prospects. Since it has insight into future production and revenue streams, This backlog highlights Trinity&rsquo;s competitive position and market leadership in the railcar manufacturing sector and reflects strong customer demand.



All in all, Trinity&rsquo;s capacity to maintain a positive backlog and secure a sizable portion of industry orders further attests to its products&rsquo; quality, strong customer connections, and responsiveness to market demand. Thus, Trinity can continue to grow and create high valuations by efficiently using its backlog and fulfilling delivery obligations.



<h2>Walgreens Boots Alliance (WBA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/wba1600-300x169.png" alt="Landscape Night View of Walgreen's Pharmacy Building Exterior. WBA stock"><div>Source: Mahmoud Suhail / Shutterstock.com</div></div>Walgreens Boots Alliance (NASDAQ:<a href="https://investorplace.com/stock-quotes/wba-stock-quote/">WBA</a>) has a&nbsp;<a href="https://seekingalpha.com/symbol/WBA/dividends/scorecard" target="_blank">4.9% dividend yield (forward)</a>. In Q1 2024, Walgreens Boots Alliance&rsquo;s revenue increase was driven mainly by pharmacy sales. According to the firm, pharmacies had a notable 10.7% rise in revenue in Q1 2023. Strong performance in comparable pharmacy sales, which increased by 13.1%, further bolstered this rise and illustrated the company&rsquo;s dominant position in the healthcare industry.



Additionally, Walgreens Boots Alliance has&nbsp;<a href="https://investor.walgreensbootsalliance.com/static-files/74e88b94-d06f-4374-b694-bd775503f7a4" target="_blank">maintained its share</a>&nbsp;of script volume in the U.S. despite several obstacles, including a weaker flu and respiratory season and Medicaid redeterminations that impacted market growth. This is a tribute to the company&rsquo;s competitive strength and devoted client base.



Overall, the company emphasizes<a href="https://investor.walgreensbootsalliance.com/static-files/74e88b94-d06f-4374-b694-bd775503f7a4" target="_blank">&nbsp;delivering</a>&nbsp;pharmacy services, such as vaccines. This helped to fuel the expansion of pharmacy sales. Similarly, this reflects the company&rsquo;s capacity to adjust to changing healthcare trends and seize the demand within the pharmacy sector to generate income.



<h2>Pfizer (PFE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/pfe-stock-3-300x169.jpg" alt="Pfizer logo on Pfizer building. Pfizer is an American pharmaceutical corporation."><div>Source: Manuel Esteban / Shutterstock.com</div></div>Pfizer (NYSE:<a href="https://investorplace.com/stock-quotes/pfe-stock-quote/">PFE</a>) offers a forward dividend&nbsp;<a href="https://seekingalpha.com/symbol/PFE/dividends/scorecard" target="_blank">yield of over 6%</a>. By the end of 2024, its cost realignment effort can generate at <a href="https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/Q4-2023-PFE-Earnings-Release.pdf" target="_blank">least $4 billion</a>&nbsp;in net cost savings annually. This reflects its focus on enhancing operational efficiency and streamlining its cost structure.



Furthermore, these cost reductions may improve Pfizer&rsquo;s profitability and margin growth. However, the efficacy of cost-cutting measures and how much they streamline processes without sacrificing innovation or product quality will determine their effectiveness.



To optimize growth potential, Pfizer has identified&nbsp;<a href="https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/PFE-USQ_Transcript_2024-01-30-1.pdf" target="_blank">five key strategic priorities</a>. These include leading the world in oncology, delivering pipeline innovation, optimizing the performance of new products, increasing margins through cost realignment, and increasing shareholder value through capital allocation. For instance, Pfizer&rsquo;s operating revenue increased by 7% due to in-line product growth and the introduction of new products. 



Overall, Pfizer&rsquo;s capability to persevere in generating revenue growth through strategic priorities.



<h2>Verizon (VZ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/vz1600-300x169.png" alt="Verizon Retail Location. Verizon delivers wireless, high-capacity fiber optics and 5G communications. VZ stock"><div>Source: RAMAN SHAUNIA / Shutterstock.com</div></div>The forward dividend yield offered by Verizon (NYSE:<a href="https://investorplace.com/stock-quotes/vz-stock-quote/">VZ</a>) is<a href="https://seekingalpha.com/symbol/VZ/dividends/scorecard" target="_blank">&nbsp;close to 6.5%</a>. Verizon&rsquo;s total revenue growth in cellular services is also influenced by its performance in various geographic markets. Compared to non-C-Band markets, deploying the C-Band spectrum in certain markets has produced improved performance indicators.



For instance, the gross add growth of consumer postpaid phones was&nbsp;<a target="_blank" href="https://www.verizon.com/about/file/69609/download?token=7JlmsuAz">eight percentage points</a>&nbsp;greater in the first 76 C-Band areas than in non-C-Band regions. Furthermore, C-Band markets had 0.04% lower churn rates, demonstrating the beneficial effects of network upgrades on customer acquisition and retention.



With forecasts indicating a&nbsp;<a target="_blank" href="https://www.verizon.com/about/file/69609/download?token=7JlmsuAz">2% to 3.5% rise</a>&nbsp;in overall wireless service revenue, Verizon expects to continue growing its income from wireless services through 2024. Anticipated positive postpaid phone net additions, sustained growth in fixed wireless access customers, and the uptake of premium unlimited plans and services all lend credence to this view.



Finally, the company&rsquo;s consumer postpaid phone customer turnover rate was steady at 0.88%. Verizon maintained steady churn rates in 2023 while enacting over $1 billion in yearly price measures, demonstrating great customer happiness and loyalty.



As of this writing, Yiannis Zourmpanos held long positions in HMN, WBA, PFE, and VZ. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines.</a>
<div>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/7-dividend-stocks-to-secure-your-financial-freedom-by-2026/">7 Dividend Stocks to Secure Your Financial Freedom by 2026</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Dividend Stocks to Secure Your Financial Freedom by 2026

Procter & Gamble, Johnson & Johnson Among 10 Dividend Growth Companies Announcing Increases In First Half Of April

In a report released today, John Barnidge from Piper Sandler maintained a Hold rating on Horace Mann Educators (HMN – Research Report), with a pric...

Piper Sandler Keeps Their Hold Rating on Horace Mann Educators (HMN)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Horace Mann Educators Stock (NYSE:HMN), Short Interest Report

People Also Watch